FDA Inspection
Tolmar, Inc.Tolmar, Inc. – FDA Inspection, Apr 6, 2018
Record Details
This FDA Inspection record concerns Tolmar, Inc., with an inspection on April 6, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 7057da85-b524-4102-acf5-d077e6f1c2a3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1056151
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
Other FDA inspections of Tolmar, Inc.
10| Date | Classification | Office | Project area |
|---|---|---|---|
| February 23, 2024 | VAI | Center for Drug Evaluation and Research | Postmarket Surv. and Epidemiology |
| January 31, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 28, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 6, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 20, 2016 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
Other documents for Tolmar, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.